Sudhir Agrawal D.phil

Sudhir Agrawal D.Phil, FRSC is an accomplished scientist and entrepreneur with extensive experience in the biotechnology and medical fields. As the Founder and President of ARNAY Sciences since October 2017, Sudhir also serves as Co-Founder and scientific advisor at Aldebaran Therapeutics, alongside roles as Chairman of the Scientific Advisory Board at Alloy Therapeutics, Inc. and as a member of various advisory boards including QurAlis, Dyne Therapeutics, SynGenis, HAYA Therapeutics SA, and Quiver Bioscience. Additionally, Sudhir holds positions as an Affiliate Professor and Visiting Professor in the Department of Medicine at UMass Chan Medical School. Sudhir's academic background includes postdoctoral research in nucleic acids at the MRC Laboratory of Molecular Biology in Cambridge, UK, and a D.Phil. in Organic Chemistry from Allahabad University, India.